PrognomiQ develops transformative diagnostic products focused on enabling early disease detection and guiding treatment strategies
PrognomiQ develops transformative diagnostic products focused on enabling early disease detection and guiding treatment strategies. The company leverages a multi-omics platform, generating high-accuracy proteomic data supplemented by genomic and metabolomic information.